Long term strategy: CEO Joseph Frick steers Independence Blue Cross in a purposeful transition

A new study found that patients with hemophilia A could safely switch directly from emicizumab to Mim8 without a washout period, meaning they did not need to stop treatment before starting the new medication and could maintain continuous protection against bleeding.

Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.

Care gaps in women’s health are closing, thanks to increased cultural awareness of gendered healthcare disparities, according to Susan Cantrell, CEO of the Academy of Managed Care Pharmacy.

Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. His guest this episode is John Baackes, the former CEO of L.A. Care Health Plan.

Absent a federal committee’s recommendation, Duchenne muscular dystrophy advocates are trying to get states to adopt screening programs.